How Big pharma let harmful anti-psychotics thrive in aged care
There is still no publicly available information on what medication individual nursing homes use, allowing harmful drugs like risperidone to thrive.
This is the second of a two-part series. Read the first part here.
After two years of at times excruciating evidence of systemic abuse inside the nation’s aged care homes the royal commission into aged care this morning handed its final report to the governor-general, having already flagged the need for sweeping change. Countering the widespread practice of chemical restraint is likely high on the commission’s priorities.
But real change will mean attacking a culture built on a decades-long reliance on antipsychotic medications which have been used to manage the symptoms of dementia. It would also mean attacking the commercial interests of the pharmaceutical and aged care industries.
Go deeper on the issues that matter.
Register your email address to get FREE access on a 21-day trial.